When asked about her favorite thing about Thea's Star of Hope, the ten-year-old explained that the organization is like a laser on pediatric brain tumors, shooting at them until, hopefully one day, poof! They disappear.
Tasigna (nilotinib) was granted Food and Drug Administration (FDA) approval, to be used in the first- and second-line setting for pediatric patients 1 year old or older who have Philadelphia chromosome–positive chronic myeloid leukemia in the chronic phase (Ph+ CML-CP).
Ryan Hamner has battled Hodgkin lymphoma four times since the age of 5, and has had some interesting hobbies since - from gardening to metal detecting. But for Hamner, two things stuck: music and creativity.